Investing-News.Com
Information for Investors

GENZYME CORPORATI, (GENZ) Stock Research - Investing-News.Com
 

 Home   Market News   Analysis   Commentary   Education   Tools   Weekly Report 

Internet Search   Stock Search
   

 

GENZYME CORPORATI, (GENZ) Stock Research Free Stock Rating

 
Company Profile
 
Genzyme Corporation operates as a biotechnology company. Its products and services focuses on rare genetic disorders, renal disease, kidney disease, cancer, orthopaedics, organ transplant, and diagnostic and predictive testing. The company operates in five segments: Renal, Therapeutics, Transplant, Biosurgery, and Diagnostics/Genetics. The Renal unit develops, manufactures, and distributes products that treat patients suffering from renal diseases, including chronic renal failure. The Therapeutics unit offers therapeutic products for genetic diseases; and other chronic debilitating diseases, including lysosomal storage disorders and other specialty therapeutics. The Transplant unit provides therapeutic products that address pretransplantation, prevention, and treatment of acute rejection in organ transplantation, as well as other auto-immune disorders. The Biosurgery unit develops, manufactures, and distributes biotherapeutics and biomaterial products, with an emphasis on products that meet medical needs in orthopaedics and broader surgical areas. The Diagnostics/Genetics unit offers vitro diagnostic products; and testing services for the oncology, and prenatal and reproductive markets. Genzyme offers its products primarily to physicians, hospitals, and treatment centers in various countries, including the United States, the United Kingdom, Ireland, the Netherlands, Belgium, France, Canada, Switzerland, and Germany. The company was founded in 1981 and is based in Cambridge, Massachusetts.

GENZYME CORPORATI Related

Genzyme Corporation Developing products and services in areas including biosurgery, therapeutic and diagnostic tools, and molecular oncology.
Genzyme Careers and Employment Opportunities Genzyme Corporation is an Equal Opportunity and Affirmative Action employer committed to a ... of Use | Privacy Policy | © 2002-2008 Genzyme Corporation. ...
Genzyme - Wikipedia, the free encyclopedia Jump to: navigation, search. Genzyme Corporation ... www.genzyme.com. Genzyme Corporation (NASDAQ: GENZ) is a biotechnology company based in Cambridge, ...
Sponsored Links:

Software Forces GENZYME CORPORATI Investors To Buy Low and Sell High The Position Cost Averaging Stock Investing Systems helps LONG-TERM investors in GENZYME CORPORATI buy low and sell high every time guaranteed. Click Here To Learn More

We Give Precision Entry & Exit Points on GENZYME CORPORATI. This software is specially designed to give precision entry and exit points on GENZYME CORPORATI, or any other stock you choose.
Click Here to learn how to take control of your trading.

How To Know When GENZYME CORPORATI Beats The Street. New Software Offers "One-Click" Stock Picks. The StockPickerRT will pick stocks for you every trading day based on earnings, volume & momentum. Maybe even GENZYME CORPORATI, if they make the cut.
Click Here & Learn To
Pick Winners In An Uncertain Market



Related Searches: computer sciences corporation and sears and court of appeals  baidu stock  the ruff times  forex signal system trading 

Research Home


Article Search


Advanced Search

StreetInsider Alerts

Latest Headlines

5-Star Stocks on the Upswing (at Motley Fool)

Poor Pozen (at Motley Fool)

Cramer's Take on Top-Searched Stocks (at TheStreet.com)

Genzyme suffers setback in Europe (at bizjournals.com)

Stocks pare losses, defensive shares rally (Reuters)

US STOCKS SNAPSHOT-Indexes pare losses, defensive shares rally (at Reuters)

Readers' Picks: TheStreet.com's Top 10 (at TheStreet.com)

Analysts' Upgrades, Downgrades: Google (at TheStreet.com)

Streetwalker: Five Beaten-Up Blue Chips (at Forbes.com)

PowerRatings Across The Indexes: MCD, KO, TEVA, GENZ, CAG, ABT (TradingMarkets.com)

  Place Our Content On Your Site!  rss Powered By The Investing System Network
© 2006 Investing-News.Com, All Rights Reserved.